Back
Royalty Pharma PLC Stock Price Chart
Sponsored
RPRX
Sponsored
My #1 Coin is...
All the details are on the next page.
Sell
32
RPRX
Royalty Pharma PLC
Last Price:
28.26
Seasonality Move:
-7.4%
7 Day Trial
ALL ACCESS PASS
$
7
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight buying pressure.
Royalty Pharma PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.07 | Buy |
20-day SMA: | 28.33 | Buy |
50-day SMA: | 29.43 | Sell |
200-day SMA: | 28.74 | Buy |
8-day EMA: | 28.17 | Buy |
20-day EMA: | 28.4 | Buy |
50-day EMA: | 28.89 | Sell |
200-day EMA: | 29.79 | Sell |
Royalty Pharma PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.35 | Sell |
Relative Strength Index (14 RSI): | 52.25 | Buy |
Chaikin Money Flow: | 1521698 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.77 - 29.33) | Buy |
Bollinger Bands (100): | (27.94 - 30.08) | Sell |
Royalty Pharma PLC Technical Analysis
Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Royalty Pharma PLC Stock
Is Royalty Pharma PLC Stock a Buy?
- Royalty Pharma PLC share price is 28.76 while RPRX 8-day simple moving average is 28.07, which is a Buy signal.
- The stock price of RPRX is 28.76 while Royalty Pharma PLC 20-day SMA is 28.33, which makes it a Buy.
- Royalty Pharma PLC 50-day simple moving average is 29.43 while RPRX share price is 28.76, making it a Sell technically.
- RPRX stock price is 28.76 and Royalty Pharma PLC 200-day simple moving average is 28.74, creating a Buy signal.
RPRX Technical Analysis vs Fundamental Analysis
Sell
32
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a Sell
The current Royalty Pharma PLC [RPRX] share price is $28.76. The Score for RPRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Royalty Pharma PLC Stock Info
Market Cap:
12.85B
Price in USD:
28.76
Share Volume:
3.94M
Royalty Pharma PLC 52-Week Range
52-Week High:
35.70
52-Week Low:
25.92
Sell
32
Royalty Pharma PLC (RPRX)
is a Sell
Royalty Pharma PLC Share Price Forecast
-
What is the Royalty Pharma PLC stock price today?
The Royalty Pharma PLC stock price is 28.76 USD today. -
Will RPRX stock go up or go down?
Royalty Pharma PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Royalty Pharma PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma PLC is overvalued.
Is Royalty Pharma PLC Stock a Buy?
- Royalty Pharma PLC share price is 28.76 while RPRX 8-day exponential moving average is 28.17, which is a Buy signal.
- The stock price of RPRX is 28.76 while Royalty Pharma PLC 20-day EMA is 28.40, which makes it a Buy.
- Royalty Pharma PLC 50-day exponential moving average is 28.89 while RPRX share price is 28.76, making it a Sell technically.
- RPRX stock price is 28.76 and Royalty Pharma PLC 200-day simple moving average is 29.79, creating a Sell signal.
Fundamental Analysis of Royalty Pharma PLC
Is Royalty Pharma PLC a good investment?
- Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.27 per share, and an increase next year of $0.40 per share.
Technical Analysis of Royalty Pharma PLC
Should I short Royalty Pharma PLC stock?
- RPRX Moving Average Covergence Divergence (MACD) indicator is -0.35, suggesting Royalty Pharma PLC is a Sell
- Royalty Pharma PLC Relative Strength Index (RSI) is 52.25, which suggest Royalty Pharma PLC is overbought
- The Bollinger Bands (25) for Royalty Pharma PLC is (27.77 - 29.33), which suggest Royalty Pharma PLC is a Sell
- The Bollinger Bands (100) for Royalty Pharma PLC is (27.94 - 30.08), which suggest Royalty Pharma PLC is a Sell
* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.